Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuous Infusion Vancomycin in Pediatric CRRT
NCT02663596Phase 1Unknown
- Sponsor
- Drexel University
- Start
- Jan 2017
- Primary completion
- Dec 2021
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of vancomycin in Gram-positive bacterial infection, sponsored by Drexel University. Primary endpoint: Number of patients with therapeutic vancomycin serum levels up to 33 months. Status: unknown.
02
Drugs
vancomycin
03
Conditions
Gram-positive bacterial infection
Beyond the preview
Go deeper on NCT02663596.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02663596.